摘要
Abstract
Objective To investigate the interventional combined abdominal heat treating middle-late ovarian cancer postoperative clinical curative ef ect and security.Methods Wil be treated in the middle-late ovarian cancer patients were randomly divided into research group and the control group by the digital meter method,the research team,intravenous chemotherapy combined abdominal hot perfusion treatment,while control group adopts pure vein chemotherapy,compared two groups of patients with the clinical therapeutic ef ect and adverse reactions.Results The incidence of adverse reactions compared with the control group patients without obvious dif erence ( 2=0.29,>0.29);The team other indicators were superior to control group,<0.05,the dif erence is statistical y significant.Conclusion Interventional combined abdominal heat treating middle-late ovarian cancer has good clinical ef ect and adverse reactions did not increase,worth clinical promotion.关键词
化疗/腹腔热灌注/中晚期/卵巢癌Key words
Chemotherapy/Intraperitoneal perfusion/Middle and late stage/Ovarian carcinoma
